Initial experience with hybrid argon plasma coagulation as a novel local treatment method for tracheobronchial mucoepidermoid carcinoma
Tracheobronchial mucoepidermoid carcinoma (MEC) is a type of salivary gland tumor. Surgical resection is the main treatment for MEC, but it is associated with risks. Hybrid argon plasma coagulation (HybridAPC®) is an innovative technique combining APC with a water cushion function which can be used...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 27, 2019
|
| In: |
Respiration
Year: 2019, Volume: 98, Issue: 5, Pages: 461-466 |
| ISSN: | 1423-0356 |
| DOI: | 10.1159/000501239 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1159/000501239 Verlag, Volltext: https://www.karger.com/Article/FullText/501239 
|
| Author Notes: | Xiaoxuan Zheng, Felix J.F. Herth, Jiayuan Sun |
| Summary: | Tracheobronchial mucoepidermoid carcinoma (MEC) is a type of salivary gland tumor. Surgical resection is the main treatment for MEC, but it is associated with risks. Hybrid argon plasma coagulation (HybridAPC®) is an innovative technique combining APC with a water cushion function which can be used for the treatment of MEC. We aimed to evaluate the efficacy and safety of HybridAPC for MEC in 2 patients diagnosed with MEC based on histological examination of biopsies. Full preoperative assessments were done by white-light bronchoscopy, autofluorescence imaging, narrow-band imaging, and radial probe endobronchial ultrasound. HybridAPC was administered after these evaluations. Both patients were followed up for more than 3 months. HybridAPC ablation was completed successfully, with no complications. HybridAPC thus appears to be a safe and efficient treatment for MEC. |
|---|---|
| Item Description: | Gesehen am 30.01.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1423-0356 |
| DOI: | 10.1159/000501239 |